Discover Top 50 Companies in Assisted Reproductive Technology: Global Share, Market Size, Revenue Report (2024-2035)

Description

According to a research report published by Spherical Insights & Consulting, The Global Assisted Reproductive Technology Market Size is projected to grow from USD 34.1 Billion in 2024 to USD 63.4 Billion by 2035, at a CAGR of 6.4 % during the forecast period 2025–2035. Future opportunities in the Assisted Reproductive Technology market include AI-driven fertility solutions, genetic screening advancements, fertility preservation, telehealth integration, male infertility treatments, and increased global access to IVF services.

 

 

Introduction                                                             

Assisted Reproductive Technology (ART) refers to medical procedures used to address infertility, primarily through methods such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and cryopreservation of embryos or gametes. These techniques assist individuals or couples in achieving pregnancy when natural conception is not possible or effective. Key driving factors of the ART market include the rising prevalence of infertility due to lifestyle changes, delayed parenthood, increasing awareness of reproductive options, supportive government regulations, advancements in laboratory and genetic screening technologies, and growing demand for fertility services among same-sex couples and single parents.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights - Download the Brochure now and dive deeper into the future of the Assisted Reproductive Technology market.

 

Assisted Reproductive Technology Market Size & Statistics

• The Market for Assisted Reproductive Technology was Estimated to be Worth USD 34.1 Billion in 2024.
• The Market is Going to Expand at a CAGR of 6.4 % Between 2025 and 2035.
• The Global Assisted Reproductive Technology Market Size is Anticipated to Reach USD 63.4 Billion by 2035.
• Europe is expected to generate the highest demand during the forecast period in the Assisted Reproductive Technology market.
• Asia Pacific is expected to grow the fastest during the forecast period in the Assisted Reproductive Technology market.

 

 

Regional growth and demand                                     

Asia Pacific is expected to grow the fastest during the forecast period in the assisted reproductive technology market. This rapid expansion is driven by several factors, including rising infertility rates, increasing awareness and acceptance of fertility treatments, and the growing trend of delayed parenthood. Additionally, improvements in healthcare infrastructure, supportive government initiatives, and the relatively lower cost of ART procedures compared to Western countries are making fertility treatments more accessible in this region. Countries such as China, India, Japan, and South Korea are emerging as key contributors, with a surge in fertility clinics and medical tourism further accelerating regional growth.

 

Europe is expected to generate the highest demand during the forecast period in the assisted reproductive technology market. Europe is expected to generate the highest demand during the forecast period in the Assisted Reproductive Technology (ART) market due to a combination of demographic, social, and regulatory factors. One major driver is the increasing incidence of infertility linked to lifestyle changes, delayed childbearing, and age-related fertility decline. Europe also has a well-established network of fertility clinics and a strong presence of advanced reproductive technologies. Moreover, the region benefits from favorable government policies, insurance coverage in some countries for fertility treatments, and widespread awareness and acceptance of ART among the population. Countries such as Spain, Denmark, and the UK are key contributors, offering liberal laws and access to both domestic and international patients, which fuels medical tourism. These factors collectively position Europe as a major hub for ART services, sustaining high demand throughout the forecast period.

 

Top 5 Emerging Reproductive Health Startups

1. Aspivix – Surgical Devices

Historically, women utilize various contraceptive options like injections, pills, and vaginal rings; however, implants and intrauterine devices (IUDs) are the most efficient. Gynecologists employ the cervical tenaculum to steady the uterus prior to IUD insertion, a process that can result in pain and bleeding. This fear of pain frequently deters women from opting for IUDs. Startups and scaleups create surgical instruments that offer a more gentle and secure experience in comparison to the cervical tenaculum. The Swiss company Aspivix develops medical devices intended for gynecological use. ASPIVIX is a device that uses vacuum suction to interact with the cervix and enables access to the uterus without causing any damage to the tissue. Additionally, the single-use tool minimizes the chance of cross-contamination, improving the procedure's safety.

 

2. Ohana Biosciences – Sperm Fertility

Numerous men and women face challenges with reproductive fertility, especially in their late thirties and forties, frequently because of lifestyle decisions. Improvements in healthcare, particularly in infertility therapy, assist countless couples globally. AI algorithms assist physicians in analyzing sperm samples to detect the different functional issues that occur within them. The US-based biotech company Ohana Biosciences creates innovative tools to detect disease alleles, spontaneous mutations, and DNA damage affecting sperm fertility. The startup utilizes machine learning and various integrative analyses to determine the functional effects of sperm diversity in males. Ohana Biosciences employs single-cell sequencing, high-throughput imaging, and cell surface profiling to identify molecular differences in sperm.

 

3. MFB Fertility – Ovulation Kits

Women are progressively having children at older ages and require solutions that support this. This involves monitoring ovulation cycles and luteinizing hormone (LH) levels, along with progesterone levels if fertilization occurs. Advancements in medical devices enable women to monitor this essential information from home, facilitating improved pregnancy planning. MFB Fertility, a startup located in the US, produces Proov, a home testing kit for female fertility. The startup’s product is user-friendly and provides precise outcomes in just 5 minutes of operation. The solution monitors the pregnanediol (PdG) levels in the bloodstream to validate ovulation cycles, enabling women to enhance the likelihood of conception.

 

4. Kiira Health – Virtual Clinic

With technological progress allowing organizations to provide services online, clinics and hospitals are adapting accordingly. Access to reproductive health information enables women to prepare and strategize for the diverse complexities associated with pregnancies, especially regarding women's health. For instance, new companies provide telehealth services that support women throughout their pregnancies. Kiira Health, a startup located in the US, operates a virtual health clinic targeting women, accessible through employers, colleges, and health insurance plans. Utilizing an AI-powered care coordinator, the startup offers medical support via chats and video calls with physicians. Their offerings include testing for sexually transmitted infections, fertility advice, as well as delivery and postpartum support.

 

5. Care Mother – Fetal Heart Monitoring

Digital health is changing how expectant mothers access healthcare for themselves and their developing baby. Wearable technologies and other IoT-enabled devices assist obstetricians and gynecologists in enhancing their support and remotely tracking the fetus's vital signs. Healthcare startups create user-friendly devices that assist expectant mothers in alleviating anxiety from the comfort of their homes. Indian startup Care Mother creates Fetosense, a device that tracks the heart activity of fetuses. The interactive machine, which operates via a smartphone, features a portable kit equipped with wireless probes that transmit test results to doctors instantly. Additionally, the device features a built-in printer and provides limitless storage for digital health records.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Assisted Reproductive Technology market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Top 10 Companies Leading the Assisted Reproductive Technology Market

1. Cook Medical Inc.
2. Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)
3. Genea Biomedx
4. Merck KGaA (EMD Serono, Inc.)
5. Millendo Therapeutics, Inc.
6. Oxford Gene Technology
7. Progyny Inc.
8. The Cooper Companies, Inc. (CooperSurgical, Inc.)
9. Thermo Fisher Scientific, Inc.
10. Vitrolife AB

 

 1. Cook Medical Inc.

Headquarters: Bloomington, Indiana, United States

Cook Medical Inc. is a global leader in developing minimally invasive medical devices used in diagnostic and therapeutic procedures. Established in 1963, the company specializes in a broad range of medical fields including reproductive health, urology, vascular interventions, and gastroenterology. In the Assisted Reproductive Technology (ART) market, Cook Medical offers a range of IVF products including embryo transfer catheters, needles, and culture media. The company emphasizes innovation, patient safety, and physician collaboration. Cook Medical is part of the Cook Group and operates worldwide, providing advanced medical solutions that help improve patient care and clinical outcomes.

 

2. Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)

Headquarters: Tokyo, Japan (Fujifilm); Santa Ana, California, USA (Irvine Scientific)

Fujifilm Holdings Corporation is a multinational conglomerate best known for imaging and healthcare technologies. Through its subsidiary, Irvine Scientific, the company plays a vital role in the ART market by providing advanced cell culture media used in IVF procedures. Irvine Scientific specializes in media designed for fertilization, embryo culture, cryopreservation, and ICSI applications. Fujifilm leverages its bioscience expertise to support innovative reproductive solutions, enhancing the success rates of ART treatments. The company’s strong focus on R&D, quality standards, and regulatory compliance ensures reliable, effective solutions for fertility clinics globally.

 

3. Genea Biomedx

Headquarters: Sydney, New South Wales, Australia

Genea Biomedx is an Australian-based medical technology company specializing in developing innovative fertility treatment equipment and systems. The company focuses on improving IVF outcomes through its integrated technology platforms, including time-lapse incubators, embryo culture media, and automation tools. Genea Biomedx aims to streamline laboratory workflows, increase standardization, and support embryologists in optimizing embryo development and selection. Their technologies are built on years of clinical research and are used by fertility clinics across the globe. The company’s collaborative approach and commitment to advancing reproductive health have positioned it as a key player in the ART market.

 

4. Merck KGaA (EMD Serono, Inc.)

Headquarters: Darmstadt, Germany (Merck KGaA); Rockland, Massachusetts, USA (EMD Serono)

Merck KGaA, operating as EMD Serono in the U.S. and Canada, is a global science and technology company active in healthcare, life science, and performance materials. In the ART space, Merck is a major player offering fertility drugs, including gonadotropins and hormone therapies, to support controlled ovarian stimulation and embryo development. With decades of experience and a strong focus on innovation and research, Merck works closely with fertility experts to improve patient outcomes. The company’s commitment to precision medicine and patient support has made it a leader in the field of reproductive endocrinology and infertility treatment.

 

5. Millendo Therapeutics, Inc.

Headquarters: Ann Arbor, Michigan, United States

Millendo Therapeutics, Inc. is a biopharmaceutical company focused on developing novel treatments for endocrine diseases, including reproductive hormone disorders. While not a direct provider of ART procedures, Millendo contributes to the field through its work on therapies that address conditions like polycystic ovary syndrome (PCOS) and hypogonadism, which impact fertility. The company’s pipeline includes innovative drug candidates targeting key hormonal pathways. Millendo is committed to addressing unmet medical needs in reproductive and endocrine health, playing an indirect but important role in supporting fertility and ART outcomes by treating underlying hormonal imbalances that affect reproductive capability.

 

Are you ready to discover more about the assisted reproductive technology market?

The report provides an in-depth analysis of the leading companies operating in the global Assisted Reproductive Technology market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

1. Cook Medical Inc.
   • Business Overview
   • Company Snapshot
   • Products Overview
   • Company Market Share Analysis
   • Company Coverage Portfolio
   • Financial Analysis
   • Recent Developments
   • Merger and Acquisitions
   • SWOT Analysis
2. Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)
3. Genea Biomedx
4. Merck KGaA (EMD Serono, Inc.)
5. Millendo Therapeutics, Inc.
6. Oxford Gene Technology
7. Progyny Inc.
8. The Cooper Companies, Inc. (CooperSurgical, Inc.)
9. Thermo Fisher Scientific, Inc.
10. Vitrolife AB

 

Conclusion

The assisted reproductive technology (ART) market is undergoing transformative growth, driven by advancements in medical technology, rising infertility rates, and increasing global awareness of reproductive options. The integration of AI, telehealth, and innovative fertility solutions is reshaping how individuals and couples approach family planning. With supportive government policies, expanding healthcare infrastructure, and the emergence of pioneering startups, both developed and developing regions are witnessing growing demand for ART services. As industry leaders and innovators continue to invest in research and development, the ART market is poised to play a critical role in the future of reproductive healthcare worldwide.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter